掃碼下載
BTC $71,892.67 +1.28%
ETH $2,186.57 +0.22%
BNB $601.28 +0.21%
XRP $1.34 +0.87%
SOL $82.94 +1.17%
TRX $0.3204 +1.05%
DOGE $0.0922 +0.86%
ADA $0.2518 +1.16%
BCH $443.34 +0.58%
LINK $8.92 +1.87%
HYPE $40.20 +3.92%
AAVE $90.02 +0.30%
SUI $0.9297 +2.29%
XLM $0.1549 -0.57%
ZEC $366.13 +15.42%
BTC $71,892.67 +1.28%
ETH $2,186.57 +0.22%
BNB $601.28 +0.21%
XRP $1.34 +0.87%
SOL $82.94 +1.17%
TRX $0.3204 +1.05%
DOGE $0.0922 +0.86%
ADA $0.2518 +1.16%
BCH $443.34 +0.58%
LINK $8.92 +1.87%
HYPE $40.20 +3.92%
AAVE $90.02 +0.30%
SUI $0.9297 +2.29%
XLM $0.1549 -0.57%
ZEC $366.13 +15.42%

彭博社:Arthur Hayes 近期重金投資某人類壽命延長公司,過去 1 年定期接受幹細胞靜脈輸注治療

2025-08-21 09:43:07
收藏

ChainCatcher 消息,据彭博社報導,BitMEX 聯合創始人 Arthur Hayes 正將投資目光轉向人類壽命延長領域,其近期重金投資了一家在墨西哥和曼谷設有診所的幹細胞企業,並加入其董事會。

過去一年他定期乘機前往接受靜脈輸注治療,直言"希望儘可能健康地延長壽命"。儘管因品牌重塑暫未透露公司名稱,但他強調:這是未來趨勢------越來越多國家正放寬幹細胞使用法規。

app_icon
ChainCatcher 與創新者共建Web3世界